Skip to main content
24 October 2025
Last updated:
Thursday 23 October 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Why pharma is paying a premium for assets
Read more
Takeovers refocus Sanofi on rare diseases
Read more
How GMO rules affect gene and cell therapies
Read more
The advance of digital medicine
Read more
Remotely controlling gene expression
Read more
Pixium Vision: A strategy for treating macular degeneration
Read more
The impact of digital technology on diagnostics
Read more
MedNous Briefing: FDA policy on digital health
Read more
The case for optimism for Europe's biotech sector
Read more
Orchard Therapeutics targets rare diseases
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
37
Page
38
Page
39
Page
40
Current page
41
Page
42
Page
43
Page
44
Page
45
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form